Next Generation News and Research

RSS

Discovery of EP2 receptor opens path to pain relief without blocking inflammation

Scientists at the NYU Pain Research Center have identified which receptor in prostaglandins-the hormone-like substance targeted by common painkillers-causes pain but not inflammation.

25 Sep 2025

Genetic modification enhances "living drugs" for blood cancers

CAR T cells are patient-derived, genetically engineered immune cells. They are "living drugs" and constitute a milestone in modern medicine. Equipping T cells, a key cell type of the immune system, with a "chimeric antigen receptor" (CAR) enables them to specifically recognize and attack cancer cells.

25 Sep 2025

Global cancer cases and deaths expected to soar by 2050 despite advances in treatment

There has been a rapid increase in the global number of cancer cases and deaths between 1990 and 2023, despite advances in cancer treatment and efforts to tackle cancer risk factors over that same time period.

24 Sep 2025

Scientists study how nanoplastics transfer across generations

You can't see nanoplastics with the naked eye, but they're everywhere - including your body.

23 Sep 2025

UC Riverside receives $2 million grant to explore how gut bacteria shape human health

One day, bottles of probiotics might do more than keep you regular -- they could help prevent disease. To get there, a $2 million grant to UC Riverside will explore how gut bacteria shape human health.

23 Sep 2025

Targeting miR-378 could offer a dual-action strategy against osteoporosis

Osteoporosis is a degenerative disease characterized by decreased bone mass and damage to bone microarchitecture, as well as increased bone fragility.

23 Sep 2025

SynGenSys introduces NK.SET synthetic promoter library to advance natural killer cell therapies

SynGenSys, a biotechnology company designing synthetic gene promoter systems to address critical bottlenecks in biopharma manufacturing and enhance cell and gene therapy development, today announced the launch of NK.SET™.

23 Sep 2025

George Mason University advances long-term study on child health

Scientists, nurses, and researchers in George Mason University's College of Public Health (CPH) have successfully progressed to the third phase of a National Institutes of Health (NIH) program studying a broad range of early life exposures on child health.

23 Sep 2025

New gluten test detects hidden wheat in food in under three minutes

With over 98% agreement with ELISA, the LEO system offers a fast, reliable method for gluten testing, supporting safer food choices for sensitive individuals.

22 Sep 2025

New neuro-sensing technique captures brainwaves from within veins

Researchers at The University of Osaka have developed a groundbreaking, minimally invasive method for recording brain activity through blood vessels. This technique could potentially transform the diagnosis and treatment of neurological conditions like epilepsy and paving the way for advanced brain-computer interfaces.

22 Sep 2025

New AI-driven algorithm can accurately predict nearly 70% of hot flashes

University of Massachusetts Amherst researchers and scientists at Embr Labs, a Boston-based start-up, have developed an AI-driven algorithm that can accurately predict nearly 70% of hot flashes before they're perceived.

17 Sep 2025

The 15th AACR cancer progress report highlights scientific advances

The American Association for Cancer Research (AACR) released the 15th edition of its annual Cancer Progress Report. A cornerstone of the AACR's educational and advocacy efforts, this comprehensive report provides the latest statistics on cancer incidence, mortality, and survivorship and highlights how federal investments in basic, translational, and clinical cancer research and cancer-related population sciences have led to impressive scientific advances that are improving health and saving lives.

17 Sep 2025

DoD awards $1.7 million grant to continue the Convergent Science Virtual Cancer Center

A University of Arizona Comprehensive Cancer Center researcher received a $1.7 million grant from the Department of Defense to continue the Convergent Science Virtual Cancer Center, which broadens the scope of education for cancer research trainees through an emergent, cross-disciplinary approach known as convergent science.

16 Sep 2025

Novel biotechnical vector integrates viral and synthetic features for targeted cancer therapy

Gene therapy offers the possibility of addressing cancer at its molecular roots by targeting disease-causing genes rather than relying solely on surgery, chemotherapy, or radiotherapy.

16 Sep 2025

RFK Jr.’s vaccine panel expected to recommend delaying hepatitis B shot for children

A key federal vaccine advisory panel whose members were recently replaced by Health and Human Services Secretary Robert F. Kennedy Jr. is expected to vote to recommend delaying until age 4 the hepatitis B vaccine that's currently given to newborns, according to two former senior Centers for Disease Control and Prevention officials.

16 Sep 2025

Study identifies thalamic pathway that reinforces alcohol seeking in withdrawal

What compels someone to keep engaging in alcohol use, even if it damages their health, relationships and wellbeing? A new study from Scripps Research offers an important clue: a small midline brain region plays a key role in how animals learn to continue drinking to avoid the stress and misery of withdrawal.

13 Sep 2025

Electrical stimulation predicts recovery potential after acute nerve injuries

This study found that, in rats, acute nerve injuries that may recover can be distinguished from those that are unlikely to recover based on the response to intraoperative electrical nerve stimulation in the acute clinical setting.

13 Sep 2025

Charity funding boosts research into inclusion body myopathy at Aston University

Muscular Dystrophy UK, a charity working on behalf of 110,000 children and adults living with more than 60 muscle-wasting conditions, has awarded £140,944 in funding to Dr. Rebecca Jones at Aston University for a project to understand the cause of a condition called inclusion body myopathy.

13 Sep 2025

Labman leads international project to develop AI-powered bioreactor platform for next-generation biologics

Labman is proud to be involved in a groundbreaking Canada-UK collaboration to revolutionize biopharmaceutical manufacturing using cutting-edge automation, AI, and real-time process control.

From Labman 13 Sep 2025

BioDlink Commends Junshi Biosciences as its Bispecific ADC Candidate JS212 Receives IND Approval

BioDlink, a leading global CDMO, extends its congratulations to Junshi Biosciences, on receiving Investigational New Drug (IND) approval

From BioDlink 12 Sep 2025

Next Generation News and Research

Discovery of EP2 receptor opens path to pain relief without blocking inflammation

Genetic modification enhances "living drugs" for blood cancers

Global cancer cases and deaths expected to soar by 2050 despite advances in treatment

Scientists study how nanoplastics transfer across generations

UC Riverside receives $2 million grant to explore how gut bacteria shape human health

Targeting miR-378 could offer a dual-action strategy against osteoporosis

SynGenSys introduces NK.SET synthetic promoter library to advance natural killer cell therapies

George Mason University advances long-term study on child health

New gluten test detects hidden wheat in food in under three minutes

New neuro-sensing technique captures brainwaves from within veins

New AI-driven algorithm can accurately predict nearly 70% of hot flashes

The 15th AACR cancer progress report highlights scientific advances

DoD awards $1.7 million grant to continue the Convergent Science Virtual Cancer Center

Novel biotechnical vector integrates viral and synthetic features for targeted cancer therapy

RFK Jr.’s vaccine panel expected to recommend delaying hepatitis B shot for children

Study identifies thalamic pathway that reinforces alcohol seeking in withdrawal

Electrical stimulation predicts recovery potential after acute nerve injuries

Charity funding boosts research into inclusion body myopathy at Aston University

Labman leads international project to develop AI-powered bioreactor platform for next-generation biologics

BioDlink Commends Junshi Biosciences as its Bispecific ADC Candidate JS212 Receives IND Approval

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News